Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerry Avorn

Showing results (51-60 of 436) with videos related to

Pageof 44
Sort By:
Nature Reviews. Drug Discovery|May 18, 2013
The most transformative drugs of the past 25 years: a survey of physiciansAaron S Kesselheim, Jerry Avorn
The New England Journal of Medicine|April 15, 2020
Drug Evaluation during the Covid-19 PandemicBenjamin N Rome, Jerry Avorn
JAMA|September 18, 2003
Internet marketing of herbal productsCharles A Morris, Jerry Avorn
Circulation|May 26, 2010
Funding for medical education: maintaining a healthy separation from industryJerry Avorn, Niteesh K Choudhry
JAMA|October 25, 2016
Approving a Problematic Muscular Dystrophy Drug: Implications for FDA PolicyAaron S Kesselheim, Jerry Avorn
JAMA|February 7, 2017
Step Therapy-Clinical Algorithms, Legislation, and Optimal PrescribingMichael A Fischer, Jerry Avorn
Health Affairs (Project Hope)|October 11, 2012
Academic detailing can play a key role in assessing and implementing comparative effectiveness research findingsMichael A Fischer, Jerry Avorn
Circulation|December 16, 2004
Comparing the costs, risks, and benefits of competing strategies for the primary prevention of venous thromboembolismJerry Avorn, Wolfgang C Winkelmayer
JAMA|January 26, 2006
Biomedical patents and the public's health: is there a role for eminent domain?Aaron S Kesselheim, Jerry Avorn
Health Affairs (Project Hope)|May 9, 2007
Educating patients about their medications: the potential and limitations of written drug informationWilliam H Shrank, Jerry Avorn
Pageof 44

Showing results (51-60 of 436) with videos related to

Sort By:
Pageof 44
Nature Reviews. Drug Discovery|May 18, 2013
The most transformative drugs of the past 25 years: a survey of physiciansAaron S Kesselheim, Jerry Avorn
The New England Journal of Medicine|April 15, 2020
Drug Evaluation during the Covid-19 PandemicBenjamin N Rome, Jerry Avorn
JAMA|September 18, 2003
Internet marketing of herbal productsCharles A Morris, Jerry Avorn
Circulation|May 26, 2010
Funding for medical education: maintaining a healthy separation from industryJerry Avorn, Niteesh K Choudhry
JAMA|October 25, 2016
Approving a Problematic Muscular Dystrophy Drug: Implications for FDA PolicyAaron S Kesselheim, Jerry Avorn
JAMA|February 7, 2017
Step Therapy-Clinical Algorithms, Legislation, and Optimal PrescribingMichael A Fischer, Jerry Avorn
Health Affairs (Project Hope)|October 11, 2012
Academic detailing can play a key role in assessing and implementing comparative effectiveness research findingsMichael A Fischer, Jerry Avorn
Circulation|December 16, 2004
Comparing the costs, risks, and benefits of competing strategies for the primary prevention of venous thromboembolismJerry Avorn, Wolfgang C Winkelmayer
JAMA|January 26, 2006
Biomedical patents and the public's health: is there a role for eminent domain?Aaron S Kesselheim, Jerry Avorn
Health Affairs (Project Hope)|May 9, 2007
Educating patients about their medications: the potential and limitations of written drug informationWilliam H Shrank, Jerry Avorn
Pageof 44